FDA Approval In-Vivo Licensing Pharma Companies 
Camargo
NOVEMBER 11, 2020
Unpacking the (Black) Box: Antares Licenses Urology Product with Boxed Warning. When the FDA requires a product’s labeling to include a boxed warning (also called a “black box warning” because the text is surrounded by black border), the potential market value of the drug often drops severely. In October, the U.S.
Drug Discovery World
OCTOBER 4, 2022
The company’s candidate screening approach recapitulates aspects of tau oligomer formation in neurodegenerative diseases and enables the identification of novel therapeutic approaches. Several of the large pharma companies have recently re-entered the dementia field. Overcoming sector challenges . million in 2022 to 12.7
Expert insights. Personalized for you.
242 
Let's personalize your content